Xavier Montalbán Gairín-rekin lankidetzan egindako argitalpenak (6)

2009

  1. A type i interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis

    Brain, Vol. 132, Núm. 12, pp. 3353-3365

  2. Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis

    Clinical Immunology, Vol. 130, Núm. 2, pp. 145-150

2008

  1. Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms

    PLoS ONE, Vol. 3, Núm. 10

  2. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis

    Journal of Neurology, Vol. 255, Núm. 8, pp. 1136-1141

2006

  1. Altered maturation of circulating dendritic cells in primary progressive MS patients

    Journal of Neuroimmunology, Vol. 175, Núm. 1-2, pp. 183-191

  2. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients

    Multiple Sclerosis, Vol. 12, Núm. 4, pp. 421-427